Hikma Pharmaceuticals Share News (HIK)

Hikma Pharmaceuticals Rejoins FTSE 100, Smurfit Kappa Joins FTSE 250

LONDON MARKET CLOSE: UK Shares Dragged Down By Commodity Weakness

LONDON MARKET CLOSE: Brexit Poll Hits Sterling, Stocks In Late Trade

Inmarsat set for FTSE demotion in quarterly review

(ShareCast News) - Satellite communications company Inmarsat could be pushed out of the FTSE 100 by Hikma Pharmaceuticals in June, according to the FTSE Russell. Changes from the latest quarterly review of the FTSE 100, to be announced on Wednesday, will take place on Friday 17 June. Earlier this m

DIRECTOR DEALINGS: Hikma Pharmaceuticals CFO Sells 20,000 Shares

US court dismisses Takeda's claims against Hikma Pharmaceuticals

(ShareCast News) - The US District Court for the district of Delaware has dismissed claims made by Takeda Pharmaceuticals USA against Hikma Pharmaceuticals and its wholly-owned US subsidiary West-Ward Pharmaceutical. Takeda had alleged the infringement of patents covering methods of use of its colch

Hikma Pharmaceuticals Says US Court Dismisses Claims Made By Takeda

Dividends Calendar - Week Ahead

Hikma paints positive picture as investors gather

(ShareCast News) - Multinational pharmaceutical group Hikma Pharmaceuticals was holding its annual general meeting in London on Thursday, where it was set to confirm a solid start to the year and reiterate its overall guidance for 2016. The FTSE 250 firm continued to expect full-year group revenue i

TOP NEWS: Hikma Reiterates Guidance For 2016 On Good Start

AGM, EGM Calendar - Week Ahead

Director dealings: Hikma gets shot in the arm as chief tops up

(ShareCast News) - Hikma Pharmaceuticals's chief Said Darwazah boosted his stake in the generic drugs firm on Wednesday to 5.49% through the acquisition of 30,000 shares at an individual price of 2,271p. The transaction was carried out by Vidacos Nominees on behalf of Darhold Limited, in which Darwa

Director dealing: Hikma directors keep buying

(ShareCast News) - Hikma Pharmaceuticals' newest board member has bought himself some skin in the game, following his chief executive's lead. US public affairs veteran John Castellani, who was appointed to the board in February, spent around £53,000 buying 2,500 shares at a price of 2,103p apiece.

DIRECTOR DEALINGS: Hikma Non-Executive Director Buys First Shares

LONDON MARKET CLOSE: Oil Rally Helps FTSE 100 To Highest 2016 Close